poor prognosis
Original Article Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients
8
Early experience with chemotherapy intensification for poor prognosis metastatic germ cell cancer and unfavorable tumor marker decline
12
DESNT : a poor prognosis category of human prostate cancer
9
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
8
SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
8
Upregulation of KIF20A correlates with poor prognosis in gastric cancer
12
DESNT: A Poor Prognosis Category of Human Prostate Cancer.
17
CD73 is associated with poor prognosis in HNSCC
13
High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer
12
Weak HIF 1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
9
Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer
9
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
8
CMTM1 v17 is associated with chemotherapy resistance and poor prognosis in non small cell lung cancer
10
Insight into the Role and Regulation of Gap Junction Genes in Lung Cancer and Identification of Nuclear Cx43 as a Putative Biomarker of Poor Prognosis
24
Downregulation of selenium binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma
8
Neutral tumor evolution in myeloma is associated with poor prognosis
12
Galectin 3 is associated with a poor prognosis in primary hepatocellular carcinoma
14
High expression of TAZ indicates a poor prognosis in retinoblastoma
9
Low expression of LOC285194 is associated with poor prognosis in colorectal cancer
7
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
8